Waisman Biomanufacturing Blog | December 12, 2024
How Extracellular Vesicles (EVs) and Secretomes are Advancing Neurological Disorder Treatments
Neurological disorders such as Alzheimer’s, Parkinson’s, and stroke present challenges in treatment due to the blood-brain barrier and complex disease mechanisms. Recent research highlights extracellular vesicles (EVs) and secretomes as transformative tools in therapeutic development. EVs, including exosomes, act as natural carriers of proteins, RNA, and lipids, facilitating targeted drug delivery to neural tissues with minimal immune response.
